Status:
COMPLETED
Transseptal Needle Versus Radiofrequency Energy for Left Atrial Access
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Baylis Medical Company
Conditions:
Heart Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a randomized controlled trial examining whether a mechanical needle versus a needle that uses radiofrequency energy is better at puncturing through a thin wall in the heart (called "transsepta...
Detailed Description
Transseptal puncture is a commonly performed procedure allowing access to the left atrium for catheter ablation. Historically, a conventional Brockenbrough needle has been used for this procedure to m...
Eligibility Criteria
Inclusion
- Patients undergoing radiofrequency ablation within the left atrium through a transseptal approach
- Patients greater than 18 years of age
Exclusion
- Patients unable to grant informed, written consent
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT01209260
Start Date
November 1 2010
End Date
November 1 2012
Last Update
February 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143